We found that the CD44+/CD24- status was associated with low/negative HER2 expression and with elevated expression of CK5/14 and EGFR, as well as with medullary histological type, all known characteristics of the basal-like subtype of breast cancer. This evidence concerns the gene CD44 and breast carcinoma.